Want to join the conversation?
$HOLX's domestic Breast Health business grew 11.2% in 2Q16 due to continued adoption of the Genius 3D mammography. International Breast Health revenue declined by low-single digits in constant currency, as 2Q15 results benefitted from sales of products that were since discontinued. Global Surgical sales grew 15.9% in constant currency in 2Q16.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.